INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME

Juan B. Yepez; Felipe A. Murati; Michele Pettito; J. Fernando Arevalo

doi:10.1097/ICB.0000000000000344

INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME

Juan B. Yepez, Felipe A. Murati, Michele Pettito, J. Fernando Arevalo

School of Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Purpose: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. Methods: Case report. Results: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. Conclusion: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.

Original language	English (US)
Pages (from-to)	236-239
Number of pages	4
Journal	Retinal Cases and Brief Reports
Volume	11
Issue number	3
DOIs	https://doi.org/10.1097/ICB.0000000000000344
State	Published - Jun 1 2017

Keywords

Susac Syndrome
branch retinal artery occlusion
encephalopathy
hearing loss
intravitreal triamcinolone

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1097/ICB.0000000000000344

Cite this

@article{e4cd6086994841e08e6a0673b3f358cb,

title = "INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME",

abstract = "Purpose: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. Methods: Case report. Results: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. Conclusion: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.",

keywords = "Susac Syndrome, branch retinal artery occlusion, encephalopathy, hearing loss, intravitreal triamcinolone",

author = "Yepez, {Juan B.} and Murati, {Felipe A.} and Michele Pettito and Arevalo, {J. Fernando}",

note = "Publisher Copyright: Copyright {\textcopyright} by Ophthalmic Communications Society, Inc.",

year = "2017",

month = jun,

day = "1",

doi = "10.1097/ICB.0000000000000344",

language = "English (US)",

volume = "11",

pages = "236--239",

journal = "Retinal Cases and Brief Reports",

issn = "1935-1089",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME

AU - Yepez, Juan B.

AU - Murati, Felipe A.

AU - Pettito, Michele

AU - Arevalo, J. Fernando

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. Methods: Case report. Results: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. Conclusion: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.

AB - Purpose: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. Methods: Case report. Results: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. Conclusion: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.

KW - Susac Syndrome

KW - branch retinal artery occlusion

KW - encephalopathy

KW - hearing loss

KW - intravitreal triamcinolone

UR - http://www.scopus.com/inward/record.url?scp=85020421649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020421649&partnerID=8YFLogxK

U2 - 10.1097/ICB.0000000000000344

DO - 10.1097/ICB.0000000000000344

M3 - Article

C2 - 27276498

AN - SCOPUS:85020421649

SN - 1935-1089

VL - 11

SP - 236

EP - 239

JO - Retinal Cases and Brief Reports

JF - Retinal Cases and Brief Reports

IS - 3

ER -

INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this